141.96
                                            Neurocrine Biosciences Inc Aktie (NBIX) Neueste Nachrichten
Neurocrine Biosciences, Inc. $NBIX Shares Sold by Tredje AP fonden - MarketBeat
Will Neurocrine Biosciences Inc. (NB3) stock boost dividends furtherEarnings Performance Report & Weekly Stock Performance Updates - newser.com
What earnings revisions data tells us about Neurocrine Biosciences Inc.Quarterly Profit Report & AI Driven Price Forecasts - newser.com
What RSI levels show for Neurocrine Biosciences Inc. (NB3) stockJuly 2025 Recap & Expert Approved Momentum Ideas - newser.com
Can Neurocrine Biosciences Inc. stock weather global recession2025 Year in Review & Low Drawdown Momentum Ideas - newser.com
Why Neurocrine Biosciences Inc. (NB3) stock could rally stronglyCPI Data & Stepwise Swing Trade Plans - newser.com
Why Neurocrine Biosciences Inc. stock remains resilientInsider Selling & AI Enhanced Trading Alerts - newser.com
Neurocrine Biosciences, Inc. (NBIX) Stock Forecasts - Yahoo! Finance Canada
How Neurocrine Biosciences Inc. stock responds to policy changesJuly 2025 Gainers & Long-Term Safe Investment Ideas - newser.com
Measuring Neurocrine Biosciences Inc.’s beta against major indices2025 Trading Volume Trends & Daily Profit Maximizing Tips - newser.com
Neurocrine Biosciences, Inc. (NBIX) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Is Neurocrine Biosciences Inc. (NB3) stock vulnerable to rate hikes2025 Dividend Review & Verified Entry Point Signals - newser.com
Neurocrine taps China biotech for NLRP3 programs: Deals Report - BioCentury
Key facts: JP Morgan Raises Neurocrine Target to $179; TransThera Deal Worth $881.5M - TradingView
Neurocrine Bio. stock price target raised to $147 by BMO Capital - Investing.com Canada
What data driven models say about Neurocrine Biosciences Inc.’s futureWeekly Stock Report & Daily Oversold Bounce Ideas - newser.com
Applying sector rotation models to Neurocrine Biosciences Inc.Market Volume Report & Risk Adjusted Swing Trade Ideas - newser.com
How big funds are accumulating Neurocrine Biosciences Inc. (NB3) stockJuly 2025 WrapUp & Free Daily Entry Point Trade Alerts - newser.com
Neurocrine Biosciences (NBIX): Assessing Valuation After Strong Q3 Results and Pipeline Progress - simplywall.st
Can Neurocrine Biosciences Inc. stock sustain revenue growth2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com
What moving averages say about Neurocrine Biosciences Inc.Portfolio Performance Report & Accurate Buy Signal Alerts - newser.com
TransThera Sciences Sells NLRP3 Inhibitor License to Neurocrine Bioscience - MarketScreener
Transthera Sciences (Nanjing) Inc announces collaboration with Neurocrine Biosciences Inc for NLRP3 inhibitors - MarketScreener
Transthera Sciences (Nanjing) Inc Announces Collaboration With Neurocrine Biosciences Inc For NLRP3 Inhibitors - TradingView
TransThera Sciences Partners with Neurocrine for NLRP3 Inhibitors Development - TipRanks
How risky is Neurocrine Biosciences Inc. stock nowEarnings Miss & Real-Time Volume Trigger Notifications - newser.com
1,945 Shares in Neurocrine Biosciences, Inc. $NBIX Purchased by Daymark Wealth Partners LLC - MarketBeat
What analysts say about Neurocrine Biosciences Inc stockMarket Timing Techniques & Explosive Trading Portfolio - earlytimes.in
Neurocrine Biosciences, Inc. (NBIX) Stock forecasts - Yahoo! Finance UK
Is It Time to Lock in Profits on Winsol Engineers Limited StockPrice Volatility Patterns & Exceptional Trading Strategies - earlytimes.in
Cantor Fitzgerald Brokers Raise Earnings Estimates for NBIX - MarketBeat
Brighton Jones LLC Invests $351,000 in Neurocrine Biosciences, Inc. $NBIX - MarketBeat
Short interest data insights for Neurocrine Biosciences Inc.Trade Analysis Report & Long-Term Safe Investment Plans - newser.com
Neurocrine Biosciences, Inc. (NBIX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Neurocrine Biosciences (NASDAQ:NBIX) Given Buy Rating at Truist Financial - MarketBeat
Canaccord Genuity Maintains Neurocrine Biosciences (NBIX) Buy Recommendation - MSN
Neurocrine Biosciences Completes Phase 2 Study on NBI-1070770 for Depression - MSN
Will Neurocrine Biosciences Inc. (NB3) stock return to pre crash levels2025 Price Targets & AI Optimized Trading Strategy Guides - newser.com
Is it time to cut losses on Neurocrine Biosciences Inc.2025 Market Sentiment & Verified Technical Trade Signals - newser.com
        In Yahoo öffnen
        |
        In Google öffnen
            |
            In Finviz öffnen
        |
        In MarketWatch öffnen
            |
            Öffnen Sie in EDGAR    
        |
        Offen in Reuters
    
    
                Kapitalisierung:
                 
                  | 
                Volumen (24h):